Navigation Links
New lead on malaria treatment
Date:5/18/2009

Approximately 350 million to 500 million cases of malaria are diagnosed each year mostly in sub-Saharan Africa. While medications to prevent and treat malaria do exist, the demand for new treatments is on the rise, in part, because malaria parasites have developed a resistance to existing medications. Now, researchers at the Johns Hopkins University School of Medicine have discovered one way to stop malaria parasite growth, and this new finding could guide the development of new malaria treatments.

"Our research on malaria is in line with Johns Hopkins' mission to address health problems on a global level," says Jun O. Liu, Ph.D., a professor of pharmacology and molecular sciences. "Our findings offer both a new potential molecular target for treating malaria and a compound that interacts at that target. These are important steps in discovering drugs that could help to treat malaria." The results of the research were published in the February 27 issue of Chemistry & Biology.

Liu's research team has for many years studied MetAP2 proteins, which are found in all organisms from humans to single-celled bacteria and essential for cell survival. They reasoned that if the malaria parasite has its own MetAP2, finding a chemical that disrupts MetAP2 function may lead to a new drug to stop parasite growth and malaria spread. So they searched a computer database of the sequence of the malaria parasite genome and found one protein very similar to human MetAP2, which they named PfMetAP2 for plasmodium falciparum, the parasite that causes malaria.

Recently other researchers reported that the natural antibiotic fumagillin can stop malaria parasites from growing, possibly by interfering with MetAP2. But the man-made version of fumagillin causes brain cells to die, so Liu's team made several compounds chemically related to fumagillin in hopes of finding one less toxic but still effective in interfering with PfMetAP2. They chose to
'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related biology news :

1. Bacteria play role in preventing spread of malaria
2. Alzheimers, asthma, cancer, malaria and TB focus of new Singapore grants
3. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
4. New hope for advances in treating malaria
5. NIH funds development of resistance-breaking insecticides to reduce malaria transmission
6. Locking parasites in host cell could be new way to fight malaria
7. Malaria immunity trigger found for multiple mosquito species
8. Researchers identify new way the malaria parasite and red blood cells interact
9. Synthetic biology can help extend anti-malaria drug effectiveness
10. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
11. LSTM and UoL secure £1.4m ($2m) to develop new magic bullet antimalarial drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... DUBLIN , Dec. 08, 2014 Research ... announced the addition of the "Biometrics Market ... http://photos.prnewswire.com/prnh/20130307/600769 ... for projects such as rural banking and upgradation ... major trends witnessed in the market. Besides the ...
(Date:12/3/2014)... Dec. 2, 2014   Marvin Test Solutions ... test solutions for military, aerospace, and manufacturing organizations, ... its successful TS-900 PXI semiconductor test platform ... of high-end systems to customers at a fraction ... to traditional ATE. "Our semiconductor ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... An international team of scientists have discovered that climate ... mammals in the late quaternary era, 50,000 years ago. Their ... to this hotly debated topic by using global data modelling ... years before present (BP) 65% of mammal species weighing over ...
... six-foot-long babies of the world,s biggest shark species, ... of an ancient shark nursery in what is now ... Institute and the University of Florida. "Adult giant ... but young sharks faced predation from larger sharks," said ...
... 2010 Recognition Award for Scientific Accomplishments at the American ... , Dr. Downey, Executive Vice President of Academic Affairs ... Jewish Health, has over 190 publications to his credit. ... 5,000 times, putting him in the top one percent ...
Cached Biology News:New study reveals link between 'climate footprints' and mass mammal 2Extinct giant shark nursery discovered in Panama 2Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments 2
(Date:12/24/2014)... Sigma-Aldrich Corporation (NASDAQ: SIAL ... the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in ... 2014, thereby completing the U.S. HSR Act antitrust ... the Company by Merck KGaA, Darmstadt, Germany.  ... to closing the transaction, which remains subject to ...
(Date:12/22/2014)... Malvern, PA & Brussels (PRWEB) December 22, 2014 ... Education (CfPIE), the global leader of technical training ... Society for Clinical Data Management (SCDM) to ... training and certification programs —providing access to the ... The partnership extends SCDM members with 10% off when ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... reviews and editorials addressing developments and pathways related ... a provocative article exploring the role of follicle-stimulating ... treatment of prostate cancer. , The article ... possibility that there could be a connection to ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... products that improve the, safety, effectiveness, and environmental impact ... and new denitrification ... ... announced today that the company has closed the first,tranche of a ...
... LANSING, Mich., March 18 Neogen Corporation,(Nasdaq: NEOG ) announces the ... When: March 25, 2008 11:00 EDT, Where: ... -- Simply log on to the web at the address ... Maynard of Neogen Corporation, +1-800-234-5333. If you are unable to participate ...
... - Data demonstrates mortality reduction in endotoxemic patients through ... of combined ... - Spectral Diagnostics Inc.,(TSX:SDI) today announced that new findings ... the combined use of,Spectral,s EAA(TM) Endotoxin Activity Assay, the ...
Cached Biology Technology:Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 2Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 3Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing 4Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine 2
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
SHP-2 Antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: